Multiparameter immunohistochemistry analysis of HIV DNA, RNA and immune checkpoints in lymph node tissue.
DNA, Viral
/ analysis
HIV
/ genetics
HIV Infections
/ diagnosis
Humans
Immune Checkpoint Inhibitors
/ analysis
Immunohistochemistry
In Situ Hybridization
Jurkat Cells
Latent Infection
/ diagnosis
Lymph Nodes
/ immunology
Predictive Value of Tests
RNA, Viral
/ analysis
T-Lymphocytes, Regulatory
/ immunology
HIV latency
Immune checkpoints
Immunohistochemistry
In situ hybridization
Lymph nodes
Microscopy
RNAscope
Journal
Journal of immunological methods
ISSN: 1872-7905
Titre abrégé: J Immunol Methods
Pays: Netherlands
ID NLM: 1305440
Informations de publication
Date de publication:
02 2022
02 2022
Historique:
received:
23
05
2021
revised:
02
09
2021
accepted:
29
11
2021
pubmed:
6
12
2021
medline:
1
2
2022
entrez:
5
12
2021
Statut:
ppublish
Résumé
The main barrier to a cure for HIV is the persistence of long-lived and proliferating latently infected CD4
Identifiants
pubmed: 34863818
pii: S0022-1759(21)00243-X
doi: 10.1016/j.jim.2021.113198
pmc: PMC9036546
mid: NIHMS1796507
pii:
doi:
Substances chimiques
DNA, Viral
0
Immune Checkpoint Inhibitors
0
RNA, Viral
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
113198Subventions
Organisme : NCI NIH HHS
ID : 75N91019D00024
Pays : United States
Informations de copyright
Copyright © 2021 Elsevier B.V. All rights reserved.
Références
J Histochem Cytochem. 2018 Jun;66(6):427-446
pubmed: 29462571
J Exp Med. 2017 Apr 3;214(4):959-972
pubmed: 28341641
AIDS. 2018 Jul 17;32(11):1491-1497
pubmed: 29746296
J Infect Dis. 2013 Oct 15;208(8):1212-20
pubmed: 23852128
J Toxicol Pathol. 2019 Oct;32(4):319-327
pubmed: 31719761
J Virol. 2003 Jul;77(13):7383-92
pubmed: 12805437
Am J Pathol. 1997 Feb;150(2):533-42
pubmed: 9033269
Immunity. 2017 Oct 17;47(4):776-788.e5
pubmed: 29045906
Proc Natl Acad Sci U S A. 1996 Jun 25;93(13):6377-81
pubmed: 8692823
Nat Med. 2016 Jul;22(7):754-61
pubmed: 27239760
J Exp Med. 1998 Jul 6;188(1):83-91
pubmed: 9653086
Methods. 2014 Nov;70(1):46-58
pubmed: 25242720
EMBO J. 2003 Apr 15;22(8):1868-77
pubmed: 12682019
Nat Commun. 2019 Feb 18;10(1):814
pubmed: 30778080
Pathog Immun. 2016 Spring;1(1):68-106
pubmed: 27430032
PLoS Pathog. 2017 Oct 26;13(10):e1006678
pubmed: 29073251
Ann Diagn Pathol. 2018 Dec;37:12-19
pubmed: 30218928
Methods Mol Biol. 2020;2148:277-298
pubmed: 32394389
PLoS Pathog. 2016 Jul 14;12(7):e1005761
pubmed: 27415008
Nat Med. 2017 Nov;23(11):1271-1276
pubmed: 28967921
PLoS Pathog. 2013;9(12):e1003799
pubmed: 24339779
J Infect Dis. 2010 Nov 15;202(10):1553-61
pubmed: 20939732
Proc Natl Acad Sci U S A. 2014 Feb 11;111(6):2307-12
pubmed: 24469825
Immunity. 2003 Sep;19(3):413-23
pubmed: 14499116
Nat Med. 1995 Dec;1(12):1284-90
pubmed: 7489410
Nat Med. 1999 May;5(5):512-7
pubmed: 10229227
Front Microbiol. 2018 Oct 02;9:2358
pubmed: 30333813
Eur J Immunol. 2010 Aug;40(8):2134-8
pubmed: 20853499
J Infect Dis. 2017 Mar 15;215(6):911-919
pubmed: 28453847
AIDS. 2020 May 1;34(6):801-813
pubmed: 32028328
Front Immunol. 2018 Oct 10;9:2341
pubmed: 30364127
J Mol Diagn. 2012 Jan;14(1):22-9
pubmed: 22166544
Viruses. 2018 Sep 30;10(10):
pubmed: 30274333
PLoS Biol. 2010 Feb 02;8(2):e1000302
pubmed: 20126379
J Exp Med. 2000 Jul 17;192(2):303-10
pubmed: 10899917
PLoS Pathog. 2013;9(6):e1003432
pubmed: 23818847
Nat Med. 2015 Feb;21(2):132-9
pubmed: 25599132
PLoS One. 2018 Mar 8;13(3):e0193829
pubmed: 29518102
Retrovirology. 2017 Jan 13;14(1):2
pubmed: 28086908
J Infect Dis. 2008 Mar 1;197(5):714-20
pubmed: 18260759